RxDoctor Payments Data

William Jones, MD

Interventional Cardiology · Durham, NCNPI 1366456063

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,640 of the $36,153 with a category attached, or 87.5%. 16 manufacturers reported payments, led by Janssen Global Services, LLC at 37.2% of the total. Reporting peaked in 2020 at $21,049 and has fallen 77.5% since, to $4,732 in 2025.

$36,153in general payments, 2019–2025

Across 59 payments — averaging $612.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Global Services, LLC$13K
  • E.r. Squibb & Sons, L.L.C.$8K
  • Pfizer$5K
  • Novartis$3K
  • Merck$2K
  • Amgen$2K
  • plus $4K from 10 others
$860,796in research payments, 2019–2025

Across 70 payments — averaging $12,297 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim International GmbH$224K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$218K
  • Novartis$150K
  • Bayer$95K
  • Abbott$67K
  • Boston Scientific$50K
  • plus $58K from 2 others

What the payments were for

  • Consulting fees$31,64088%
  • Speaking & faculty fees$1,3504%
  • Travel & lodging$1,4394%
  • Food & beverage$1,7235%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,153 in reported general payments places this provider in the 80th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$146,739
Medicare patients
623
Services billed
1,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$61,340
JardianceEmpagliflozin25$29,225
EntrestoSacubitril/Valsartan31$28,582
Atorvastatin Calcium125$1,583
Metoprolol Succinate125$1,465
Ezetimibe50$1,227
ClopidogrelClopidogrel Bisulfate92$1,176
Rosuvastatin Calcium92$976
Losartan Potassium80$822
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$580
Metoprolol Tartrate53$561
Prasugrel Hcl13$517
Isosorbide Mononitrate ErIsosorbide Mononitrate38$489
Amlodipine Besylate60$473
Spironolactone40$456

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$4,900$61,34059 claims
Boehringer IngelheimJardiance$37$29,22525 claims
NovartisEntresto$2,977$28,58231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 180 interventional cardiology providers in North Carolina.

Other interventional cardiology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →